We are live on ! Find out more
FBLG icon

FibroBiologics
FBLG

Fund managers haven’t disclosed any holdings of FBLG yet.

FBLG Hedge Fund Activity: Q1 2026 in Review

17 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in FibroBiologics (FBLG) for Q1 2026, worth a combined $291K — down 71% from $994K a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of FBLG and 4 opened new positions — a net loss of 27 holders — while 4 trimmed existing stakes and 6 added.

The largest buyer was Fund Evaluation Group, opening a new position worth an estimated $308K. The largest seller was Millennium Management, exiting entirely with an estimated $64.9K sold.

  • 17 institutional investors held FibroBiologics (FBLG) as of Q1 2026, down from 45 in Q4 2025.
  • Funds reported $291K of FibroBiologics stock for Q1 2026, down 71% quarter-over-quarter.
  • 4 funds opened new FibroBiologics positions in Q1 2026 and 31 closed out, a net change of -27 holders.
  • The largest FibroBiologics buyer in Q1 2026 was Fund Evaluation Group, an estimated $308K added.
  • The largest FibroBiologics seller in Q1 2026 was Millennium Management, an estimated $64.9K sold.

Based on aggregated 13F filings for Q1 2026.